Webinar: IRA Update: Key considerations for 2023
By Xcenda
Now available on-demand
President Joe Biden signed the Inflation Reduction Act (IRA) into law in August 2022. Since then, many in biopharma have been assessing how the law might affect drug pricing and drug spending.
Even though several components of the IRA's drug pricing measure go into effect in 2023, several outstanding questions for biopharma still remain.
Join AmerisourceBergen's Jennifer Snow, Vice President of Market Economics, and Corey Ford, Vice President of Reimbursement and Policy Insights, as they discuss what's next for IRA.
You won't want to miss
- Key dates for the Medicare Drug Price Negotiations Program
- The IRA implementation timeline
- Key drug pricing areas to watch in 2023
Topics:
Policy
